Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-03 5:23 pm Purchase | 13G | CYBIN INC. CYBN | TANG CAPITAL MANAGEMENT LLC | 1,105,433 5.500% | 1,105,433 (New Position) | View |
| 2024-11-29 2:00 pm Purchase | 13G | JOURNEY MED CORP COM DERM | TANG CAPITAL MANAGEMENT LLC | 1,523,938 7.300% | 1,523,938 (New Position) | View |
| 2024-11-14 4:26 pm Purchase | 13G | LIANBIO SPONSORED ADS LIANY | TANG CAPITAL MANAGEMENT LLC | 8,051,815 7.500% | 8,051,815 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | CYTOMX THERAPEUTICS INC CTMX | TANG CAPITAL MANAGEMENT LLC | 7,811,760 9.990% | 7,811,760 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | EVOLUS INC EOLS | TANG CAPITAL MANAGEMENT LLC | 4,847,399 7.700% | 4,847,399 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | KalVista Pharmaceuticals Inc. KALV | TANG CAPITAL MANAGEMENT LLC | 4,321,547 9.990% | 4,321,547 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | PRECISION BIOSCIENCES INC DTIL | TANG CAPITAL MANAGEMENT LLC | 623,332 8.600% | 623,332 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | ADICET BIO INC ACET | TANG CAPITAL MANAGEMENT LLC | 8,216,960 9.970% | 8,216,960 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | ANAPTYSBIO INC ANAB | TANG CAPITAL MANAGEMENT LLC | 1,330,879 4.400% | 1,330,879 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | BIOATLA INC BCAB | TANG CAPITAL MANAGEMENT LLC | 874,076 1.800% | 874,076 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | TANG CAPITAL MANAGEMENT LLC | 600,000 4.980% | 600,000 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | LENZ Therapeutics Inc. LENZ | TANG CAPITAL MANAGEMENT LLC | 766,940 2.800% | 766,940 (New Position) | View |
| 2024-11-14 4:00 pm Purchase | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | TANG CAPITAL MANAGEMENT LLC | 294,626 2.300% | 294,626 (New Position) | View |
| 2024-11-14 4:00 pm Unchanged | 13G | QUINCE THERAPEUTICS, INC QNCX | TANG CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-08 4:56 pm Purchase | 13D | ESSA PHARMA INC EPIX | TANG CAPITAL MANAGEMENT LLC | 4,300,000 9.700% | 4,300,000 (New Position) | View |
| 2024-10-24 4:08 pm Purchase | 13G | Monopar Therapeutics MNPR | TANG CAPITAL MANAGEMENT LLC | 200,000 5.100% | 200,000 (New Position) | View |
| 2024-10-08 4:20 pm Purchase | 13D | KEZAR LIFE SCIENCES INC NE KZR | TANG CAPITAL MANAGEMENT LLC | 7,200,000 9.900% | 7,200,000 (New Position) | View |
| 2024-09-30 09:00 am Purchase | 13G | iTeos Therapeutics Inc. ITOS | TANG CAPITAL MANAGEMENT LLC | 2,407,800 6.600% | 2,407,800 (New Position) | View |
| 2024-09-18 4:26 pm Purchase | 13D | Singular Genomics Systems Inc. OMIC | TANG CAPITAL MANAGEMENT LLC | 372,000 14.900% | 372,000 (New Position) | View |
| 2024-09-12 4:10 pm Purchase | 13D | Aurinia Pharmaceuticals Inc. AUPH | TANG CAPITAL MANAGEMENT LLC | 7,229,500 5.100% | 7,229,500 (New Position) | View |